QQ客服 官方微博 反馈留言

	Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
	Chen, Li; Hao, Ying; Cong, Xiliang; Zou, Menghua; Li, Sen; Zhu, Lihua; Song, Hongjiang; Xue, Yingwei
	2019
卷号	18
关键词	neoadjuvant chemotherapy gastric cancer S-1 plus oxaliplatin oxaliplatin and capecitabine platelet-to-lymphocyte ratio
ISSN号	1533-0346
DOI	10.1177/1533033819829485
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6337451
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Chen, Li,Hao, Ying,Cong, Xiliang,et al. Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy[J],2019,18.
APA	Chen, Li.,Hao, Ying.,Cong, Xiliang.,Zou, Menghua.,Li, Sen.,...&Xue, Yingwei.(2019).Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.,18.
MLA	Chen, Li,et al."Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy".18(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。